In clinical studies, the link between serum IL-15 levels and disease severity in patients with early arthritis has been demonstrated [10]; in addition, genetic variants in IL-15 were shown to associate with joint destruction in RA in a multicohort study, suggesting a direct role for this cytokine in articular bone erosion [11], [12]. The gene discussed is IL15; the disease is rheumatoid arthritis.